These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9108773)

  • 1. Factor VLeiden and thrombophilia.
    Kalafatis M; Mann KG
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):620-7. PubMed ID: 9108773
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor V: an old star shines again.
    Rosing J; Tans G
    Thromb Haemost; 1997 Jul; 78(1):427-33. PubMed ID: 9198191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state.
    Dahlbäck B
    J Lab Clin Med; 1995 May; 125(5):566-71. PubMed ID: 7738422
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor V: Dr. Jeckyll and Mr. Hyde.
    Kalafatis M; Mann KG
    Adv Exp Med Biol; 2001; 489():31-43. PubMed ID: 11554589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The haemostatic function of the vascular endothelial cell.
    Bull HA; Machin SJ
    Blut; 1987 Aug; 55(2):71-80. PubMed ID: 3111566
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protein C--a selective inhibitor of blood coagulation].
    Dmoszyńska-Giannopoulou A; Rupniewska ZM
    Pol Arch Med Wewn; 1984 May; 71(5):313-6. PubMed ID: 6435099
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial thrombophilia: a complex genetic disorder.
    Koeleman BP; Reitsma PH; Bertina RM
    Semin Hematol; 1997 Jul; 34(3):256-64. PubMed ID: 9241710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new cause of familial thrombophilia: resistance to the effect of activated protein C].
    Emmerich J; Alhenc-Gelas M; Gandrille S; Fiessinger JN; Aiach M
    Presse Med; 1994 Sep; 23(28):1285-7. PubMed ID: 7984524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.
    Press RD; Goodnight SH
    West J Med; 1995 May; 162(5):450-2. PubMed ID: 7785262
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B
    Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation factor V and thrombophilia: background and mechanisms.
    Segers K; Dahlbäck B; Nicolaes GA
    Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulant protein C system: structure and function].
    Martín García E
    Rev Clin Esp; 1988 Sep; 183(4):197-203. PubMed ID: 2854287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z; Seligsohn U; Zivelin A; Eldor A
    Harefuah; 1995 Jul; 129(1-2):1-5, 80. PubMed ID: 7557699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of factor V and factor Va on APC-induced cleavage of human factor VIII.
    Váradi K; Rosing J; Tans G; Schwarz HP
    Thromb Haemost; 1995 Apr; 73(4):730-1. PubMed ID: 7495090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Protein cofactors of coagulation and fibrinolytic systems--high molecular weight kininogen, factor V, factor VIII, thrombomodulin, protein S, and HRG].
    Koide T
    Nihon Rinsho; 1989 Apr; 47(4):816-27. PubMed ID: 2545945
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor V antigen levels and venous thrombosis: risk profile, interaction with factor V leiden, and relation with factor VIII antigen levels.
    Kamphuisen PW; Rosendaal FR; Eikenboom JC; Bos R; Bertina RM
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1382-6. PubMed ID: 10807757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation.
    Váradi K; Rosing J; Tans G; Pabinger I; Keil B; Schwarz HP
    Thromb Haemost; 1996 Aug; 76(2):208-14. PubMed ID: 8865533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.